Industry NewsMaze Therapeutics announces Phase 1 trial initiation evaluating MZE001 as a potential oral treatment for Pompe Disease
Product NewsNew portfolio of chromatography and mass spectrometry consumables assures quality and performance
Application NotesTransfection efficiency of GFP- and mcherry-expressing HeLas evaluated on a microplate reader